Vendor, West Lafayette, IN, part of Akina Inc.
Akina, Inc.
UEI WTBLC3LE13U1, CAGE 3ZDR8
1 award and $555,872 obligated between August 23, 2024 and December 22, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $555,872 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40123C00192Definitive Contract, August 23, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | This Is a Firm Fixed Price Fornew Plga Analytical Methods for Mini-Size Complex Long-Acting Injectable Formulations.NAICS 541714, PSC B504 | $555,872 |
- Places of performance
- Indiana
- Product and service codes
- B504 Chemical/Biological Studies and Analysis
- Transactions
- 3 across 1 awards